Cholesterol

Data demonstrates the efficacy of CRESTOR in treating elevated cholesterol

Published in Clinical Oncology Week, November 22nd, 2004

New data presented from five studies (DISCOVERY, COMETS, MERCURY I, URANUS, RADAR) involving more than 5,000 patients provide further evidence of the efficacy of CRESTOR (rosuvastatin calcium) in improving cholesterol levels in patients with elevated cholesterol with either atherosclerosis, coronary artery disease, type 2 diabetes or metabolic syndrome.

The data were presented at the XV International Symposium on Drugs Affecting Lipid Metabolism (DALM) in Venice, Italy.

Results from direct Statin comparison of LDL-C values: an evaluation of rosuvastatin LDL therapy (DISCOVERY), presented for the first time, show that CRESTOR, at the usual start dose...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2004-11-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry